ArticleClinical and molecular hepatology2026

Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on "Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations".

Donghee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.